TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22425883

Group type: EXPERIMENTAL
Intervention: Naproxcinod
Number of subjects: 349

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 349

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Naproxcinod, Naproxen, Ibuprofen
Number of subjects: 349
Study: 19702662

Group type: EXPERIMENTAL
Intervention: Universal intervention designed to reduce depressive symptoms, implemented over a 3-year period, including a comprehensive classroom curriculum programme, enhancements to the school climate, improvements in care pathways, and community forums.
Number of subjects: 5634

Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 5634

Group type: EXPERIMENTAL
Intervention: Intervention (staff-rated assessments of school climate)
Number of subjects: 5634
Study: 19090319

Group type: EXPERIMENTAL
Intervention: Experimental group received five 15-minute bright light pulses during night shifts, wore dark sunglasses outside, slept in dark bedrooms, and received outdoor afternoon light exposure.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group remained in normal room light during night shifts, wore lighter sunglasses, and had unrestricted sleep and outdoor light exposure.
Number of subjects: 24
Study: 16911871

Group type: EXPERIMENTAL
Intervention: HAT (home-based)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: CHAT (group-based)
Number of subjects: 119
Study: 12820071

Group type: EXPERIMENTAL
Intervention: Developmentally supportive care (DSC) training program
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no DSC training)
Number of subjects: 25
Study: 11256825

Group type: EXPERIMENTAL
Intervention: Revien and Gabor's Sports Vision programme (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Revien's Eyerobics (Group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo condition involving reading (Group 3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition involving physical practice only (Group 4)
Number of subjects: 40
Study: 9429755

Group type: EXPERIMENTAL
Intervention: Low antenatal attachment
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Negative mood states and lack of social support during pregnancy
Number of subjects: 238
Study: 8430630

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous nitroglycerin
Number of subjects: 20
Study: 3323353

Group type: EXPERIMENTAL
Intervention: Real time B mode ultrasound imaging (USI)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Bilateral contrast ascending venography
Number of subjects: 430
Study: 29406607

Group type: COMPARATOR
Intervention: Lifestyle modification (LFS)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Sulfonylurea (SU)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 278
Study: 28073964

Group type: EXPERIMENTAL
Intervention: 600 mg tenofovir disoproxil fumarate/400 mg emtricitabine
Number of subjects: 12
Study: 26235929

Group type: EXPERIMENTAL
Intervention: Moderate-to-large pericardial effusion (PE) detected by cardiac magnetic resonance (CMR)
Number of subjects: 780

Group type: COMPARATOR
Intervention: No intervention specified for control group
Number of subjects: 780
Study: 24117234

Group type: EXPERIMENTAL
Intervention: R-HCVAD/R-MA
Number of subjects: 59

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 59
Study: 21372246

Group type: EXPERIMENTAL
Intervention: ReJoyce ET
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional ET
Number of subjects: 9
Study: 18309452

Group type: EXPERIMENTAL
Intervention: 100 mg hydrocortisone (HC) replacement therapy on the day of surgery, tapered off thereafter
Number of subjects: 37

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 100 mg hydrocortisone (HC) replacement therapy
Number of subjects: 37
Study: 16540883

Group type: EXPERIMENTAL
Intervention: Famciclovir 250 mg bid for 16 weeks
Number of subjects: 390

Group type: COMPARATOR
Intervention: Valacyclovir 500 mg qd for 16 weeks
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Famciclovir 250 mg bid for 10 weeks
Number of subjects: 390

Group type: COMPARATOR
Intervention: Valacyclovir 500 mg qd for 10 weeks
Number of subjects: 390
Study: 12749505

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days
Number of subjects: 526

Group type: COMPARATOR
Intervention: Clarithromycin 250 mg twice daily for 10 days
Number of subjects: 526
Study: 10895108

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol-supplemented MCT/LCT/omega-3-acid triglycerides (MLF, 5/4/1 w/w/w, 20%) emulsion
Number of subjects: 33

Group type: COMPARATOR
Intervention: soybean oil-based LCT emulsion (20%)
Number of subjects: 33
Study: 8938284

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no aprotinin)
Number of subjects: 0
Study: 29452031

Group type: EXPERIMENTAL
Intervention: Traditional spinal immobilization (TSI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spinal motion restriction (SMR)
Number of subjects: 20
Study: 28488729

Group type: EXPERIMENTAL
Intervention: C-seal
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control
Number of subjects: 402
Study: 25857597

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 749

Group type: COMPARATOR
Intervention: Doppler
Number of subjects: 749

Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 749
Study: 23934773

Group type: EXPERIMENTAL
Intervention: high MUFA diet (38% E from fat, 20% E as MUFA)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: low-fat, high-complex carbohydrate diet (28% E from fat)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: low-fat, high-complex carbohydrate diet supplemented with 1.24 g/day of long-chain n-3 PUFA
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: fat challenge reflecting the same fatty acid composition as the original diets
Number of subjects: 39

Group type: COMPARATOR
Intervention: different types of diets
Number of subjects: 39
Study: 21946315

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 198
Study: 19454562

Group type: EXPERIMENTAL
Intervention: On-Pump Group (using CPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Off-Pump Group (without CPB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 16231256

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 277

Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate
Number of subjects: 277

Group type: COMPARATOR
Intervention: Other Licensed Antifungal Therapies (OLAT) after amphotericin B deoxycholate
Number of subjects: 277

Group type: COMPARATOR
Intervention: Salvage therapy with lipid formulation of amphotericin B after initial treatment with amphotericin B deoxycholate
Number of subjects: 277
Study: 12528605

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 865

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 865
Study: 10331750

Group type: EXPERIMENTAL
Intervention: Regular training group (n=8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-level training group (n=8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n=8)
Number of subjects: 24
Study: 8952582

Group type: COMPARATOR
Intervention: Valsalva maneuver
Number of subjects: 54

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 54
Study: 1941028

Group type: EXPERIMENTAL
Intervention: Consent A (n = 52)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Consent B (n = 48)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients citing quantitative information
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients not citing quantitative information
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with minimal or severe symptoms
Number of subjects: 100
Study: 6179976

Group type: EXPERIMENTAL
Intervention: Combined use of chlorpheniramine maleate and ranitidine hydrochloride
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ranitidine hydrochloride alone
Number of subjects: 25
Study: 31272111

Group type: EXPERIMENTAL
Intervention: Walking training with blood flow restriction (BFR‐W)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Walking training without blood flow restriction (NOR‐W)
Number of subjects: 21
Study: 27889667

Group type: EXPERIMENTAL
Intervention: 40 cmH2O PRM
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 60 cmH2O PRM
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (passive exsufflation)
Number of subjects: 90
Study: 26305390

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) using the GlucoDay(®)S device
Number of subjects: 35

Group type: COMPARATOR
Intervention: Blinded continuous glucose monitoring (Control)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Both RT-CGM and Control
Number of subjects: 35
Study: 24411758

Group type: EXPERIMENTAL
Intervention: Acutely ill AN participants
Number of subjects: 3

Group type: COMPARATOR
Intervention: Recovered participants
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Explicit affective patterns
Number of subjects: 3
Study: 22066898

Group type: EXPERIMENTAL
Intervention: Vaginal cones
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vaginal cones and PFMT
Number of subjects: 45
Study: 19515265

Group type: EXPERIMENTAL
Intervention: Nursing intervention via telephone follow-up (n = 288)
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group (n = 280)
Number of subjects: 568
Study: 17342994

Group type: EXPERIMENTAL
Intervention: Reinhartdt and sea cucumber capsule (RSC) combined with Donepezil
Number of subjects: 68

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reinhartdt and sea cucumber capsule (RSC)
Number of subjects: 68
Study: 15509080

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 0.3% Triclosan, 1,000ppm fluoride and 0.13% calcium glycerophosphate in a natural calcium carbonate base
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 0.2% Triclosan and 1,000ppm fluoride in a precipitated calcium carbonate base
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 0.3% Triclosan, 1,000ppm fluoride and Gantrez in a silica base
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available toothpastes without the above actives
Number of subjects: 0
Study: 11673815

Group type: EXPERIMENTAL
Intervention: Ritonavir 200 mg bid + saquinavir 600 mg bid (Rito-Saq)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nelfinavir 1,000 mg bid + saquinavir 600 mg bid (Nelf-Saq)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nelf-Saq and Rito-Saq
Number of subjects: 31
Study: 9065232

Group type: COMPARATOR
Intervention: Fee-for-Service (FFS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary Care Case Management (PCCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 7699617

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both MTX and AZA
Number of subjects: 64
Study: 3197710

Group type: EXPERIMENTAL
Intervention: FDDF oral administration of lorazepam 4 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intravenous administration of lorazepam 4 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison of both formulations
Number of subjects: 16
Study: 30030579

Group type: EXPERIMENTAL
Intervention: Early weight-bearing from day 1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-weight-bearing for 6 weeks (Control)
Number of subjects: 60
Study: 25450847

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss plus exercise (D + E)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss-only (D)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Exercise-only (E)
Number of subjects: 450
Study: 23175178

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) - performed 10 headers at 11.2 m/s in 10 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG) - simulated headers
Number of subjects: 0
Study: 21546878

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between Rosuvastatin and Placebo
Number of subjects: 0
Study: 18579216

Group type: EXPERIMENTAL
Intervention: Quetiapine (400-800 mg/day) plus lithium/divalproex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus lithium/divalproex
Number of subjects: 0
Study: 17123184

Group type: EXPERIMENTAL
Intervention: Upper-limb interval-training program combined with a general rehabilitation program
Number of subjects: 14

Group type: COMPARATOR
Intervention: General rehabilitation program
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups (training and control)
Number of subjects: 14
Study: 12885680

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 40 mg enoxaparin sodium
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg enoxaparin
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Oral tenoxicam
Number of subjects: 427
Study: 10558945

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (single-dose)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Erythromycin (7-day course)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and Erythromycin
Number of subjects: 245
Study: 8914204

Group type: EXPERIMENTAL
Intervention: Tamoxifen in combination with chemotherapy for metastatic melanoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate as an adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroid hormones
Number of subjects: 0
Study: 1677820

Group type: EXPERIMENTAL
Intervention: Pipecuronium (PIP), 0.10 mg/kg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Vecuronium (V), 0.12 mg/kg
Number of subjects: 82
Study: 6340546

Group type: EXPERIMENTAL
Intervention: Synthetic adhesive moisture vapor permeable (SAM) dressings
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fine mesh gauze dressings
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tegaderm
Number of subjects: 60

Group type: COMPARATOR
Intervention: Op-Site
Number of subjects: 60
Study: 30765403

Group type: EXPERIMENTAL
Intervention: Spatial and machine learning analysis of structural heart disease
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Creation of a detailed cardiovascular map and predictive machine learning system
Number of subjects: 2400
Study: 30448030

Group type: EXPERIMENTAL
Intervention: TURBT plus immediate postoperative epirubicin (50 mg)
Number of subjects: 236

Group type: COMPARATOR
Intervention: TURBT alone (control group)
Number of subjects: 236
Study: 28070882

Group type: EXPERIMENTAL
Intervention: Loading dose of 180 mg ticagrelor pre-PCI, followed by ticagrelor 90 mg twice daily post-PCI (group TT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Maintenance dose of ticagrelor 90 mg twice daily (group CT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg daily post-PCI (group CC)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Loading dose of ticagrelor (group TT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Platelet aggregation measurement in a separate cohort (diabetic and non-diabetic patients)
Number of subjects: 77
Study: 25111795

Group type: EXPERIMENTAL
Intervention: Intubation for 4 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intubation for 6 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intubation for 2 hours
Number of subjects: 12
Study: 25606328

Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT) and splinting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham LLLT and splinting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Only splints
Number of subjects: 50
Study: 21981745

Group type: EXPERIMENTAL
Intervention: Media campaign with culturally sensitive educational material
Number of subjects: 1052
Study: 19826937

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) supplementation for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17402468

Group type: EXPERIMENTAL
Intervention: Mounted condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Harnessed condition
Number of subjects: 10
Study: 15605971

Group type: EXPERIMENTAL
Intervention: Mequinol 2%/tretinoin 0.01%
Number of subjects: 216

Group type: COMPARATOR
Intervention: Hydroquinone 3%
Number of subjects: 216
Study: 11480450

Group type: EXPERIMENTAL
Intervention: General practitioner letter
Number of subjects: 6133

Group type: EXPERIMENTAL
Intervention: Flag in women's notes prompting discussion by health professionals
Number of subjects: 6133

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 6133

Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 6133
Study: 9629829

Group type: EXPERIMENTAL
Intervention: Exhaustive telephone prompts by a medical peer
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Embossed pen with the questionnaire
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Advance letter prompt
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Single attempt advance telephone prompt by a non-medical research assistant
Number of subjects: 4

Group type: COMPARATOR
Intervention: Overall response rates
Number of subjects: 4

Group type: COMPARATOR
Intervention: Male GPs
Number of subjects: 4

Group type: COMPARATOR
Intervention: Female GPs
Number of subjects: 4
Study: 7931040

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 3144366

Group type: EXPERIMENTAL
Intervention: Active management
Number of subjects: 1695

Group type: COMPARATOR
Intervention: Physiological management
Number of subjects: 1695
Study: 31662030

Group type: EXPERIMENTAL
Intervention: Adjuvant Cisplatin/Vinorelbine (ACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy or surgery only (based on model recommendation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-risk patients receiving ACT
Number of subjects: 0
Study: 30646158

Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition (PN) initiated after 1 week
Number of subjects: 289

Group type: COMPARATOR
Intervention: Early parenteral nutrition (PN) initiated within 24 hours
Number of subjects: 289
Study: 26820239

Group type: EXPERIMENTAL
Intervention: Triclosan dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 30
Study: 24876615

Group type: EXPERIMENTAL
Intervention: CGM real time
Number of subjects: 41
Study: 23342329

Group type: EXPERIMENTAL
Intervention: Pressed PCRs (IPS e.max-Press, Ivoclar Vivadent)
Number of subjects: 25

Group type: COMPARATOR
Intervention: CAD/CAM PCRs (ProCAD, Ivoclar Vivadent)
Number of subjects: 25
Study: 21557868

Group type: EXPERIMENTAL
Intervention: Condition A - cooked carrots, pasta and chicken
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Condition B - cooked green garden beans, pasta and chicken
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Condition AB - carrot sticks, green garden beans, pasta and chicken
Number of subjects: 98
Study: 18438256

Group type: EXPERIMENTAL
Intervention: Heavy-Resistance Circuit (HRC) training
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional Strength (TS) training
Number of subjects: 10
Study: 16507973

Group type: EXPERIMENTAL
Intervention: Structured educational programme
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 12925054

Group type: EXPERIMENTAL
Intervention: Motivational and solution-focused therapy group intervention
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study: 10726795

Group type: EXPERIMENTAL
Intervention: Early vitrectomy (duration between 3-6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Deferred vitrectomy (duration of more than 6 months)
Number of subjects: 40
Study: 9082675

Group type: EXPERIMENTAL
Intervention: Tedisamil 0.3 mg/kg BW
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tedisamil 0.4 mg/kg BW
Number of subjects: 32
Study: 1533595

Group type: EXPERIMENTAL
Intervention: Long-term therapeutic intervention directed at airways obstruction and hyperresponsiveness
Number of subjects: 274

Group type: COMPARATOR
Intervention: Therapeutic intervention directed at airways obstruction alone
Number of subjects: 274
Study: 7423284

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 tablets administered intravaginally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of the Bishop score
Number of subjects: 0
Study: 31778436

Group type: EXPERIMENTAL
Intervention: High-intensity laser therapy at 1064 nm and 60 J/cm2 for 10 min (HILT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy at 785 nm and 8 J/cm2 for 8 min (LLLT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham (HILT placebo)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham (LLLT placebo)
Number of subjects: 68
Study: 28179223

Group type: EXPERIMENTAL
Intervention: Whole grain-rich diet (207 ± 39 g whole grains plus 40 ± 5 g dietary fiber/d)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Refined grain-based diet (0 g whole grains plus 21 ± 3 g dietary fiber/d)
Number of subjects: 81
Study: 25894405

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus, L. plantarum, Bifidobacterium lactis, Saccharomyces boulardii)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22867838

Group type: EXPERIMENTAL
Intervention: Modified bimanual laryngoscopy (group M)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional bimanual laryngoscopy (group C)
Number of subjects: 78